News & Updates

Show Multimedia Only
Semaglutide scores again, this time for HFpEF in obese

Semaglutide scores again, this time for HFpEF in obese

03 Oct 2023 byElvira Manzano

Once weekly injection of semaglutide causes weight loss in obese patients with heart failure with preserved ejection fraction (HFpEF), with positive shifts in symptoms and improvements in physical limitations in the STEP-HFpEF trial presented at ESC 2023.

03 Oct 2023